| Literature DB >> 17320978 |
Julius Kapala1, Dan Jang, Jay Patel, Kathleen Biers, Marek Smieja, Max Chernesky.
Abstract
The Digene Hybrid Capture 2 (HC2) assay for high-risk human papillomavirus (HPV) identified 92 (28.7%) infected women by testing 320 SurePath liquid-based Pap samples and a hybrid capture 2 (HC2) sampler collection. HPV positivity was predictive for high-grade lesions. A majority of women had normal cervical readings although 15.8% were HPV-positive. Half of the patients with a reading of atypical squamous cells of undetermined significance (ASCUS) (n=16) were HPV-positive.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17320978 DOI： 10.1016/j.jviromet.2007.01.028
Source DB: PubMed Journal: J Virol Methods ISSN： 0166-0934 Impact factor: 2.014